Safety and Risk Benefit Analyses
- 20 July 2022
- book chapter
- Published by Springer Nature
- p. 1961-1980
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals: Report of the International Society for Pharmacoeconomics and Outcomes Research Risk Benefit Management Working GroupValue in Health, 2012
- Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agentsDiabetic Medicine, 2009
- A quantitative approach to benefit-risk assessment of medicines – part 1: the development of a new model using multi-criteria decision analysisPharmacoepidemiology and Drug Safety, 2007
- Assessing A Structured, Quantitative Health Outcomes Approach To Drug Risk-Benefit AnalysisHealth Affairs, 2007
- Perspectives on the Use of Data Mining in PharmacovigilanceDrug Safety, 2005
- Safety Related Drug-Labelling ChangesDrug Safety, 2004
- Benefit‐risk analysis: a proposal using quantitative methodsPharmacoepidemiology and Drug Safety, 2003
- Impact of cisapride label changes on codispensing of contraindicated medicationsPharmacoepidemiology and Drug Safety, 2003
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001
- A new proposal for benefit-less-risk analysis in clinical trialsControlled Clinical Trials, 1994